Chronic back pain affects millions of people and treatment today is limited to pain management (mainly pain medication) or major invasive surgery (fusion). We believe that there must be a further option which is an injectable therapy that can significantly delay further disc degeneration and the associated pain. As Robert Guilleaume has had to deal with these back pain issues himself, he welcomed the opportunity to be CEO for NC Biomatrix.
Robert Guilleaume is the CEO of NC Biomatrix and has over 35 years of experience in the medical device business with multinational companies and start-ups.
Missed this edition of EHV Innovation Café? Don’t worry, we’ve got your back (pun intended). Rewatch the presentation and Q&A below: